University of California San Francisco
Give to UCSF
A sexual health strategy called Doxy-PEP, which involves taking doxycycline after condomless sex, is highly effective in reducing bacterial STIs but is still associated with a limited rise in resistant strains of bacteria.
UCSF’s Heart and Vascular Center participation in a new Cardiogenic Shock Registry aims to improve treatment for cardiogenic shock types.
UCSF researchers found that distributing pro-COVID-19 vaccine information in EDs in English and Spanish increased vaccine acceptance, especially among Latinos and those without primary care physicians.
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
Angela Phillips, PhD, leads research that could help predict future viruses like COVID and the antibodies we might use to treat them.
Balyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
A new digital tool helps calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
A UCSF study finds increase in percutaneous coronary intervention (PCI) at low-volume hospitals over time for all races, insurance types and incomes.
Diane Havlir, MD, UCSF’s Weiss Professor, an AIDS pioneer, and an infectious disease leader, is partnering with the local Latinx community to protect vulnerable San Franciscans from COVID-19 and other diseases.
A grandmother showed telltale signs of a common endocrine disorder. But a puzzling lab result put the detective skills of physicians Joan Addington-White, MD, and Rob Weber, MD ’19, PhD ’17, to the test.
